Fulgent Historical Income Statement

FLGT Stock  USD 21.69  0.06  0.28%   
Historical analysis of Fulgent Genetics income statement accounts such as Interest Expense of 38.9 M or Selling General Administrative of 93.4 M can show how well Fulgent Genetics performed in making a profits. Evaluating Fulgent Genetics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fulgent Genetics's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Fulgent Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fulgent Genetics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

About Fulgent Income Statement Analysis

Fulgent Genetics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fulgent Genetics shareholders. The income statement also shows Fulgent investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Fulgent Genetics Income Statement Chart

Fulgent Genetics Income Statement is one of the three primary financial statements used for reporting Fulgent's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fulgent Genetics revenue and expense. Fulgent Genetics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Fulgent Genetics' Cost Of Revenue is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 180.5 M in 2024, despite the fact that Net Loss is likely to grow to (61.7 M).

Total Revenue

Total revenue comprises all receipts Fulgent Genetics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Fulgent Genetics minus its cost of goods sold. It is profit before Fulgent Genetics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Fulgent Genetics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Cost Of Revenue is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 180.5 M in 2024, despite the fact that Net Loss is likely to grow to (61.7 M).
 2021 2022 2023 2024 (projected)
Gross Profit777.1M366.9M96.6M179.1M
Total Revenue992.6M619.0M289.2M266.7M

Fulgent Genetics income statement Correlations

0.440.530.60.510.460.530.260.290.260.590.310.570.570.12-0.310.10.310.461.00.340.620.730.42
0.440.830.880.270.150.87-0.27-0.23-0.270.92-0.160.710.86-0.5-0.95-0.57-0.10.980.44-0.080.960.750.9
0.530.830.980.660.530.980.110.180.110.950.20.950.99-0.1-0.64-0.150.260.780.530.280.840.880.95
0.60.880.980.670.560.970.110.20.110.990.220.950.99-0.12-0.72-0.170.30.830.590.320.910.90.92
0.510.270.660.670.980.560.560.860.560.630.610.850.670.44-0.10.440.90.240.50.910.410.690.39
0.460.150.530.560.980.430.590.920.590.520.630.760.550.490.00.50.950.120.460.960.30.590.24
0.530.870.980.970.560.430.140.070.140.930.250.90.97-0.08-0.67-0.140.150.810.530.170.870.830.97
0.26-0.270.110.110.560.590.140.681.00.00.990.290.10.960.460.940.61-0.310.260.6-0.130.03-0.05
0.29-0.230.180.20.860.920.070.680.680.160.670.470.20.660.330.690.99-0.240.280.99-0.060.29-0.13
0.26-0.270.110.110.560.590.141.00.680.00.990.290.10.960.460.940.61-0.310.260.6-0.130.03-0.05
0.590.920.950.990.630.520.930.00.160.00.10.920.97-0.24-0.8-0.290.270.880.590.30.940.910.89
0.31-0.160.20.220.610.630.250.990.670.990.10.380.20.930.360.890.61-0.210.310.61-0.030.110.06
0.570.710.950.950.850.760.90.290.470.290.920.380.960.09-0.520.050.540.660.570.560.770.890.81
0.570.860.990.990.670.550.970.10.20.10.970.20.96-0.12-0.68-0.170.290.810.560.310.880.90.93
0.12-0.5-0.1-0.120.440.49-0.080.960.660.96-0.240.930.09-0.120.680.990.56-0.540.120.55-0.37-0.15-0.25
-0.31-0.95-0.64-0.72-0.10.0-0.670.460.330.46-0.80.36-0.52-0.680.680.740.19-0.96-0.310.17-0.88-0.59-0.72
0.1-0.57-0.15-0.170.440.5-0.140.940.690.94-0.290.890.05-0.170.990.740.59-0.60.10.58-0.43-0.17-0.32
0.31-0.10.260.30.90.950.150.610.990.610.270.610.540.290.560.190.59-0.110.311.00.050.37-0.05
0.460.980.780.830.240.120.81-0.31-0.24-0.310.88-0.210.660.81-0.54-0.96-0.6-0.110.46-0.090.920.690.85
1.00.440.530.590.50.460.530.260.280.260.590.310.570.560.12-0.310.10.310.460.340.620.730.42
0.34-0.080.280.320.910.960.170.60.990.60.30.610.560.310.550.170.581.0-0.090.340.080.4-0.03
0.620.960.840.910.410.30.87-0.13-0.06-0.130.94-0.030.770.88-0.37-0.88-0.430.050.920.620.080.870.85
0.730.750.880.90.690.590.830.030.290.030.910.110.890.9-0.15-0.59-0.170.370.690.730.40.870.76
0.420.90.950.920.390.240.97-0.05-0.13-0.050.890.060.810.93-0.25-0.72-0.32-0.050.850.42-0.030.850.76
Click cells to compare fundamentals

Fulgent Genetics Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fulgent Genetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Fulgent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Fulgent Genetics Stock. Highlighted below are key reports to facilitate an investment decision about Fulgent Genetics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.
Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Fulgent Stock analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(5.63)
Revenue Per Share
9.71
Quarterly Revenue Growth
0.041
Return On Assets
(0.03)
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.